ropivacaine has been researched along with Experimental Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, K; Li, G; Liu, W; Ting, W; Yang, J; Zhang, Y | 1 |
1 other study(ies) available for ropivacaine and Experimental Neoplasms
| Article | Year |
|---|---|
Ropivacaine inhibits tumor angiogenesis via sodium-channel-independent mitochondrial dysfunction and oxidative stress.
Topics: A549 Cells; Animals; Humans; Mice; Mitochondria; Neoplasm Proteins; Neoplasms, Experimental; Neovascularization, Pathologic; Oxidative Stress; Ropivacaine; Sodium Channels | 2019 |